Cargando…
New Therapeutic Targets for Intraocular Pressure Lowering
Primary open-angle glaucoma (POAG) is a leading cause of irreversible and preventable blindness and ocular hypertension is the strongest known risk factor. With current classes of drugs, management of the disease focuses on lowering intraocular pressure (IOP). Despite of their use to modify the cour...
Autores principales: | Rocha-Sousa, A., Rodrigues-Araújo, J., Gouveia, Petra, Barbosa-Breda, João, Azevedo-Pinto, S., Pereira-Silva, P., Leite-Moreira, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914177/ https://www.ncbi.nlm.nih.gov/pubmed/24558600 http://dx.doi.org/10.1155/2013/261386 |
Ejemplares similares
-
Accommodative Exercises to Lower Intraocular Pressure
por: Stokkermans, Thomas J., et al.
Publicado: (2020) -
Cataract Surgery to Lower Intraocular Pressure
por: Berdahl, John P.
Publicado: (2009) -
Is the observed lowering of intraocular pressure due to treatment?
por: Thomas, Ravi, et al.
Publicado: (2013) -
The intraocular pressure-lowering properties of intravenous paracetamol
por: van den Heever, Henning, et al.
Publicado: (2016) -
Additive Intraocular Pressure-Lowering Effects of Ripasudil with Glaucoma Therapeutic Agents in Rabbits and Monkeys
por: Kaneko, Yoshio, et al.
Publicado: (2017)